1. Home
  2. TMCWW vs XOMAO Comparison

TMCWW vs XOMAO Comparison

Compare TMCWW & XOMAO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo TMC the metals company Inc.

TMCWW

TMC the metals company Inc.

HOLD

Current Price

$0.25

Market Cap

0.0

ML Signal

HOLD

Logo AGNC Investment Corp.

XOMAO

AGNC Investment Corp.

N/A

Current Price

$25.42

Market Cap

0.0

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
TMCWW
XOMAO
Founded
2011
N/A
Country
Canada
United States
Employees
48
13
Industry
Metal Mining
Biotechnology: Pharmaceutical Preparations
Sector
Basic Materials
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
N/A
N/A
IPO Year
N/A
N/A

Fundamental Metrics

Financial Performance
Metric
TMCWW
XOMAO
Price
$0.25
$25.42
Analyst Decision
Analyst Count
0
0
Target Price
N/A
N/A
AVG Volume (30 Days)
149.5K
3.5K
Earning Date
03-24-2025
N/A
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
N/A
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$0.22
$24.86
52 Week High
$3.84
$26.40

Technical Indicators

Market Signals
Indicator
TMCWW
XOMAO
Relative Strength Index (RSI) 45.22 56.03
Support Level $0.24 $25.23
Resistance Level $0.50 $25.47
Average True Range (ATR) 0.05 0.04
MACD -0.01 0.01
Stochastic Oscillator 31.58 87.50

Price Performance

Historical Comparison
TMCWW
XOMAO

About TMCWW TMC the metals company Inc.

TMC The Metals Co Inc is a deep seabed minerals developer focused on the collection, processing and refining of polymetallic nodules found on the seafloor in international waters of the Clarion Clipperton Zone (CCZ), approximately 1,500 miles (or 2,400 kilometers) south-west of San Diego, California. The company operates as a single operating and reportable segment, namely exploration of seafloor polymetallic nodules, which includes the development of a metallurgical process to treat such seafloor polymetallic nodules.

About XOMAO AGNC Investment Corp.

XOMA Royalty Corp is a biotechnology royalty aggregator playing a role in helping biotech companies achieve their goal of improving human health. XOMA acquires the potential future economics associated with pre-commercial therapeutic candidates that have been licensed to pharmaceuticals or biotechnology companies. XOMA acquires future economic rights, the seller receives non-dilutive, non-recourse funding that can use to advance their internal drug candidate(s) or for general corporate purposes. Geographically, the company operates in Switzerland, United States, Asia Pacific, Europe and Others.

Share on Social Networks: